SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021892
Filing Date
2020-08-13
Accepted
2020-08-13 16:24:45
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_biomxinc.htm 10-Q 474950
2 COMPOSITE COPY OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPA f10q0620ex3-1_biomxinc.htm EX-3.1 32210
3 COMPOSITE COPY OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPA f10q0620ex3-2_biomxinc.htm EX-3.2 34073
4 CERTIFICATION f10q0620ex31-1_biomxinc.htm EX-31.1 15755
5 CERTIFICATION f10q0620ex31-2_biomxinc.htm EX-31.2 14832
6 CERTIFICATION f10q0620ex32_biomxinc.htm EX-32 7845
  Complete submission text file 0001213900-20-021892.txt   2679907

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE phge-20200630.xml EX-101.INS 383636
8 XBRL SCHEMA FILE phge-20200630.xsd EX-101.SCH 35491
9 XBRL CALCULATION FILE phge-20200630_cal.xml EX-101.CAL 33571
10 XBRL DEFINITION FILE phge-20200630_def.xml EX-101.DEF 103495
11 XBRL LABEL FILE phge-20200630_lab.xml EX-101.LAB 234543
12 XBRL PRESENTATION FILE phge-20200630_pre.xml EX-101.PRE 183887
Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 201099674
SIC: 2836 Biological Products, (No Diagnostic Substances)